Summary: Depuy Hip Replacement Recall
DePuy Hip Replacement Recall
The complaints about defective hip implants made by DePuy Orthopaedics, Inc., a part of Johnson and Johnson’s Medical Devices & Diagnostics group, had been sending to the U.S. Food and Drug Administration over the past two years. On August 24, 2010, after a warning letter from the F.D.A. and the new medical information of these faulty hip implants from the UK National Joint Registry, DePuy finally recalled about 93,000 of these artificial joints. What are the ethical risks and consequences associated with DePuy’s products? What should DePuy do to correct these failures?
DePuy Inc., a member of the Johnson & Johnson Family of Companies, a world leader in health care products and services, was founded in 1895. DePuy Inc. develops and markets products under the DePuy Orthopaedics, Inc.; DePuy Spine, Inc.; Codman & Shurtleff, Inc.; and DePuy Mitek units.
DePuy Orthopaedics Inc. was the first commercial orthopaedics company in the U.S. To become a global leader in orthopaedic devices and supplies, the company has committed to the innovation in patient care and improvement of movement in patients’ lives …show more content…
This culture is followed still today to achieve the commitments stated in the Credo. However, the growing number of operating companies continues to grow and put strain on J&J, a parent company. As in this case, defective and unsafe hip implants made by Depuy Ordopaetics, units of J&J, caused problems in patients who used these products. Both two types of Depuy hip implant didn’t have a sufficient screw or cement to be able to hold on to the socket itself, causing dislocation between the two parts of artificial hip joint that move against each other. Patients usually experienced severe pain and swelling and had difficulty walking or inability to walk. These problems were quickly identified through surgery and
The complaints about defective hip implants made by DePuy Orthopaedics, Inc., a part of Johnson and Johnson’s Medical Devices & Diagnostics group, had been sending to the U.S. Food and Drug Administration over the past two years. On August 24, 2010, after a warning letter from the F.D.A. and the new medical information of these faulty hip implants from the UK National Joint Registry, DePuy finally recalled about 93,000 of these artificial joints. What are the ethical risks and consequences associated with DePuy’s products? What should DePuy do to correct these failures?
DePuy Inc., a member of the Johnson & Johnson Family of Companies, a world leader in health care products and services, was founded in 1895. DePuy Inc. develops and markets products under the DePuy Orthopaedics, Inc.; DePuy Spine, Inc.; Codman & Shurtleff, Inc.; and DePuy Mitek units.
DePuy Orthopaedics Inc. was the first commercial orthopaedics company in the U.S. To become a global leader in orthopaedic devices and supplies, the company has committed to the innovation in patient care and improvement of movement in patients’ lives …show more content…
This culture is followed still today to achieve the commitments stated in the Credo. However, the growing number of operating companies continues to grow and put strain on J&J, a parent company. As in this case, defective and unsafe hip implants made by Depuy Ordopaetics, units of J&J, caused problems in patients who used these products. Both two types of Depuy hip implant didn’t have a sufficient screw or cement to be able to hold on to the socket itself, causing dislocation between the two parts of artificial hip joint that move against each other. Patients usually experienced severe pain and swelling and had difficulty walking or inability to walk. These problems were quickly identified through surgery and